New Delhi: The Serum Institute of India (SII) is likely to start manufacturing Russian vaccine Sputnik-V in India in the coming days. The Serum Institute has sought permission from the Drug Controller General of India (DCGI) to grant trial licences to produce Sputnik-V. This information was given by the state-run news agency ANI quoting its sources.

The Serum Institute, which produces covid vaccine covishield, has also applied for test analysis and examination. Tell us that Sputnik V is currently being manufactured by Dr Reddy's Laboratories in India. The Russian vaccine has been approved for emergency use by India's drug controller. Russia's vaccine was registered in India on April 12 under the Emergency Use Authority process and the use of the Russian vaccine began on May 14. RDIF and Panesia have agreed to produce 100 million doses a year of biotech Sputnik V.

Sputnik-V is so far registered in 66 countries with a total population of more than 320 million. the RDIF and The Gamalaya Center said sputnik V's efficacy is 97.6 per cent, based on an analysis of corona virus infection rate data among vaccinators in Russia with both doses of Sputnik V from December 5 last year to March 31 this year.

Vaccination Policy: Kerala Govt Blames Centre In Response To HC Query on vaccine policy

First SPV in India will operate large multi-village surface water supply schemes Punjab

Manya: Take all the precautions even after getting fully vaccinated.